![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
The purpose of this study was to compare the effects of human recombinant interleukin 1, α and β, on articular cartilage. The effects of rIL-1α and rIL-1β on proteoglycan degradation and synthesis following treatment of bovine articular cartilage in serum-free organ culture were quantified. Purified human IL-1 and both rIL-1α and rIL-1α induced a two-fold or greater increase in glycosaminoglycan (GAG) release from cultured articular cartilage. Levels of rIL-1α as low as 15 pM induced increased proteoglycan degradation whereas identical levels of rIL-1β did not. Killing of the cartilage cells abolished induced GAG release by all forms of IL-1. Analysis of proteoglycan size following IL-1 treatment showed limited degradation of material released into the culture medium or remaining within cartilage. Both forms of recombinant IL-I inhibited GAG synthesis when continually present in the culture medium. Actinomycin D and cycloheximide inhibited IL-1 dependent cartilage destruction whereas indomethacin did not.